Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019)

Ironwood Pharmaceuticals' (IRWD) quarterly Cash from Discontinued Operations came in at 11364000.0 in Q1 2019, up 191.53% quarter-over-quarter from 3898000.0 in Q4 2018.

Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Cash from Discontinued Operations across 3 years of filings, most recently posting 11364000.0 for Q1 2019.

  • Cash from Discontinued Operations for Q1 2019 came in at 11364000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was 11364000.0 (up 281.73% YoY), and the FY2019 annual result was 11364000.0, down 3.76% from the prior year.
  • Cash from Discontinued Operations came in at 11364000.0 for Q1 2019 at Ironwood Pharmaceuticals, up from 3898000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 11364000.0 in Q1 2019 to a low of 2605000.0 in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Ironwood Pharmaceuticals 546.74 Mn 326.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2019 11.36 Mn
Mar 31, 2019 11.36 Mn
Dec 31, 2018 3.90 Mn
Dec 31, 2018 3.90 Mn
Sep 30, 2018 2.61 Mn
Sep 30, 2018 2.61 Mn
Sep 30, 2010 -3.53 Mn
Sep 30, 2010 -3.53 Mn